ESR1 and breast carcinoma: Estrogen-receptor alpha (ERα)-dependent enhancers in the human breast cancer cell line MCF-7 allow tracking of events after hormone treatment at high temporal resolution in a well-studied model system in which enhancers and their target genes, as well as many of the molecular mechanisms operating during enhancer activation, are well defined [16].